DY logo

DY

Dycom Industries Inc.

$391.62
+$10.62(+2.79%)
64
Overall
55
Value
81
Tech
57
Quality
How is this score calculated?
Market Cap
$8.45B
Volume
460.37K
52W Range
$131.37 - $445.53
Target Price
$461.70

Company Overview

Mkt Cap$8.45BPrice$391.62
Volume460.37KChange+2.79%
P/E Ratio36.2Open$380.18
Revenue$4.7BPrev Close$381.00
Net Income$233.4M52W Range$131.37 - $445.53
Div YieldN/ATarget$461.70
Overall64Value55
Quality57Technical81

No chart data available

About Dycom Industries Inc.

Dycom Industries, Inc. provides specialty contracting services to the telecommunications infrastructure and utility industries in the United States. The company offers engineering services to telecommunications providers, including the planning and design of aerial, underground, and buried fiber optic, copper, and coaxial cable systems; placement of cables, related structures, and drop lines for telephone companies and cable multiple system operators; program and project management, and inspection personnel; and wireless networks in connection with the deployment of macro cell and new small cell sites. It also provides construction, maintenance, and installation services, such as placement and splicing of copper, fiber, and coaxial cables; tower construction, lines and antenna installation, foundation and equipment pad construction, and small cell site placement for wireless carriers, as well as equipment installation and material fabrication, and site testing services; underground facility locating services, including locating telephone, cable television, power, water, sewer, and gas lines for utility companies; installation and maintenance of customer premise equipment, including digital video recorders, set top boxes, and modems for cable system operators; and construction and maintenance services for electric and gas utilities, and other customers. Dycom Industries, Inc. was incorporated in 1969 and is based in Palm Beach Gardens, Florida.

Sector: Industrials
Industry: Engineering & Construction

Latest News

Fudan-Zhangjiang Enrolls First Patient in Phase I Trial of Novel Ovarian Cancer Surgical Imaging Drug

An announcement from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( ($HK:1349) ) is now available. Shanghai Fudan-Zhangjiang Bio-Pharmaceutical ...

TipRanks HongKong Auto-Generated Newsdesk7 hours ago

UBS downgrades Norsk Hydro Asa (0Q11) to a Hold

TipRanks Auto-Generated Intelligence Newsdesk8 hours ago

Telsey Advisory Remains a Buy on Target (TGT)

TipRanks Auto-Generated Intelligence Newsdesk9 hours ago

IDEAYA, AstraZeneca launch global IDE849-Imfinzi lung cancer trial

TipRanks Auto-Generated Newsdesk11 hours ago

Analysts’ Top Technology Picks: Snowflake (SNOW), GoDaddy (GDDY)

Brian Anderson13 hours ago
ABCD
1SymbolPriceChangeVol
2DY$391.62+2.8%460.37K
3
4
5
6

Get Dycom Industries Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.